Under construction – not a live service
Sign in
Active, not recruitingNo phase

Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal Neuralgia

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Trial details

Who runs it
Abbasi Shaheed Hospital
Trial code
NCT07252453
Record updated
26 November 2025
Original description
In this Study investigator is comparing the effectiveness and outcomes of two drugs used un the treatment of trigeminal neuralgia , Carbamazepine vs OxcarbazepineRead full original descriptionShow less

Comparison of Carbamazepine and Oxcarbazepine In the Treatment of Trigeminal Neuralgia

In this Study investigator is comparing the effectiveness and outcomes of two drugs used un the treatment of trigeminal neuralgia , Carbamazepine vs Oxcarbazepine

Exclusion: Prior surgical treatment for TN; Epilepsy; Drug allergy or intolerance; [Expanded] Uncontrolled hypertension; [Expanded] Psychiatric disorders; Other cranial neuralgias; Hepatic/renal dysfunction; Pregnant/lactating women.

Inclusion Criteria:; Age 18-60 years; Either gender; TGN diagnosis for ≥2 weeks (according to ICHD-3 criteria¹).

ClinicalTrials.gov NCT07252453

Under construction, not live – Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal Neuralgia (NCT07252453) – Frontlight Research